GlassScriptPrepare for your visit
James A Singer
Gastroenterology (Internal Medicine) · Glendale, AZ · NPI 1962478818
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,015.92
in general payments reported to CMS, 2019-2025
Who reported paying
General payments only, top 6 by amount.
- Gilead Sciences, INC. $499.74
- Abbvie INC. $498.96
- Takeda Pharmaceuticals U.S.A., INC. $430.76
- Janssen Biotech, INC. $390.85
- Pfizer INC. $164.90
- Genzyme Corporation $142.86
Drugs and devices associated with these payments
Skyrizi Entyvio Dupixent Zeposia Ibsrela Cimzia Simponi Simponi Aria Remicade Stelara Rinvoq Linzess
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw James Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/43225/james-a-singer